PreveCeutical Medical Inc Capital Reinvestment Ratio

Latest as of September 2020: 0.04x

PreveCeutical Medical Inc capital reinvestment ratio. PreveCeutical Medical Inc (18H) has a Capital Reinvestment Ratio of 0.04x as of September 2020, meaning it reinvests 0% of its operating cash flow (€520.22K) in capital expenditures (€21.18K). Check total reinvestment intensity of PreveCeutical Medical Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

€520.22K

EUR

Capital Expenditures

€21.18K

EUR

Data as of

Sep 2020

Most recent filing

Capital Reinvestment Ratio of PreveCeutical Medical Inc (2020–2020)

Capital reinvestment ratio of PreveCeutical Medical Inc from 2020 to 2020. This chart tracks PreveCeutical Medical Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore PreveCeutical Medical Inc net asset momentum to track the company's year-over-year net asset growth rate.

PreveCeutical Medical Inc Capital Reinvestment Ratio by Year (2020–2020)

PreveCeutical Medical Inc capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see 18H cash generation efficiency.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change
2020	0.04x	€64.59K	€2.65K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow